Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes
Por um escritor misterioso
Descrição
A Box of Chemistry to Inhibit the MEN1 Tumor Suppressor Gene Promoting Leukemia - Ozyerli‐Goknar - 2021 - ChemMedChem - Wiley Online Library
Therapeutic implications of menin inhibition in acute leukemias
Liquid‒liquid phase separation: roles and implications in future cancer treatment
Frontiers MRD Tailored Therapy in AML: What We Have Learned So Far
Precision Oncology and Gender Medicine – Moving Forward, Slowly but Surely
The clinical impact of the molecular landscape of acute myeloid leukemia
Targeting LSD1 for acute myeloid leukemia (AML) treatment - ScienceDirect
Targeting the undruggable: menin inhibitors ante portas
Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study - The Lancet Haematology
SEC Filing — Kura Oncology, Inc.
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
de
por adulto (o preço varia de acordo com o tamanho do grupo)
